Management of bleeding associated with dabigatran and rivaroxaban: A survey of current practices

Lisa M. Baumann Kreuziger, Mark T Reding

Research output: Contribution to journalArticlepeer-review

15 Scopus citations
Original languageEnglish (US)
Pages (from-to)e161-e163
JournalThrombosis Research
Issue number2
StatePublished - Aug 2013

Bibliographical note

Funding Information:
We acknowledge NIH T32 Training grant 5T32HL00706 for funding LBK’s time to complete this project. The funding source had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.

Funding Information:
A NIH T32 training grant supported LBK’s fellowship. MTR served as consultant, speaker, advisory board member, and has received research funding from Novo Nordisk, Baxter, Bayer, Biogen Idec, Octapharma, and Pfizer.

Cite this